LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase) inhibitors: A long path explored for potent drug design
Sudhir Kumar Pal, Sanjit Kumar
Topics & Concepts
AntibioticsDrugDrug candidateDrug resistanceLimitingBiologyDrug developmentMicrobiologyPharmacologyMechanical engineeringEngineeringRNA and protein synthesis mechanismsPeptidase Inhibition and AnalysisBiochemical and Molecular Research